TrialCirculation2019

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.

Remo H M Furtado et al.PubMed ↗Publisher ↗

No numbers read from the abstract.